Maternal Probiotic Intervention to Improve Gut Health (MPIGH)
Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal, and Zambia
Sponsor: Aga Khan University
Listed as NCT05922683, this PHASE2 trial focuses on Environmental Enteric Dysfunction and Stunting and remains completed. Sponsored by Aga Khan University, it has been updated 6 times since 2023, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
6 versions recorded-
Aug 2025 — Present [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Feb 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jul 2023 — Mar 2024 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aga Khan University
- Bill and Melinda Gates Foundation
- Institut Pasteur de Dakar
- International Centre for Diarrhoeal Disease Research, Bangladesh
- University of Zambia
For direct contact, visit the study record on ClinicalTrials.gov .